✦ LIBER ✦

Comparative Effectiveness: The Fourth Hurdle in Drug Development and a Role for Clinical Pharmacology

✍ Scribed by Honig, P K

Book ID: 109846205
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 366 KB
Volume: 89
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2010.302

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit and Risk Assessment in Drug Deve

Benefit and Risk Assessment in Drug Development and Utilization: A Role for Clinical Pharmacology

✍ Honig, P 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

The Economics of Drug Development: A Gri

The Economics of Drug Development: A Grim Reality and a Role for Clinical Pharmacology

✍ Honig, P; Lalonde, R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

ERRATUM: The Economics of Drug Developme

ERRATUM: The Economics of Drug Development: A Grim Reality and a Role for Clinical Pharmacology

📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

Developing and implementing a model for

Developing and implementing a model for changing physicians’ prescribing habits – the role of clinical pharmacy in leading the change

✍ E. Schwartzberg; S. Rubinovich; D. Hassin; J. Haspel; A. Ben-Moshe; M. Oren; S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

From ultrasocial to antisocial: a role f

From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

✍ I S McGregor; P D Callaghan; G E Hunt 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 271 KB

Clinical and genetic risk factors for th

Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study

✍ S.K. Sharma; K.K. Turaga; A. Balamurugan; P.K. Saha; R.M. Pandey; N.K. Jain; V.M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Genetic susceptibility of the host to multi-drug resistant tuberculosis (MDR-TB) is not fully understood. We undertook a case-control study at a tertiary care center at New Delhi, India to identify the clinical and genetic predictors of MDR-TB as compared to the drug sensitive TB cases. Patients wit